2024 欧洲共识指南:日光性角化病、上皮紫外线诱发的异常增生和区域癌化的诊断、治疗和预防

2024-03-07 欧洲皮肤病学论坛 J Eur Acad Dermatol Venereol 发表于上海

光化性角化病(AK)是一种常见的皮肤角化细胞发育不良,是皮肤鳞状细胞癌(cSCC)的潜在前兆。本文主要针对AK以及上皮紫外线诱发的异常增生和区域癌化的诊断、治疗和预防提供指导建议。

中文标题:

2024 欧洲共识指南:日光性角化病、上皮紫外线诱发的异常增生和区域癌化的诊断、治疗和预防

英文标题:

European consensus-based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV-induced dysplasia and field cancerization

发布机构:

欧洲皮肤病学论坛

发布日期:

2024-03-07

简要介绍:

光化性角化病(AK)是一种常见的皮肤角化细胞发育不良,是皮肤鳞状细胞癌(cSCC)的潜在前兆。本文主要针对AK以及上皮紫外线诱发的异常增生和区域癌化的诊断、治疗和预防提供指导建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2024 欧洲共识指南:日光性角化病、上皮紫外线诱发的异常增生和区域癌化的诊断、治疗和预防.pdf)] GetToolGuiderByIdResponse(projectId=1, id=428bd1c0036252bb, title=2024 欧洲共识指南:日光性角化病、上皮紫外线诱发的异常增生和区域癌化的诊断、治疗和预防, enTitle=European consensus-based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV-induced dysplasia and field cancerization, guiderFrom=J Eur Acad Dermatol Venereol, authorId=0, author=, summary=光化性角化病(AK)是一种常见的皮肤角化细胞发育不良,是皮肤鳞状细胞癌(cSCC)的潜在前兆。本文主要针对AK以及上皮紫外线诱发的异常增生和区域癌化的诊断、治疗和预防提供指导建议。, cover=https://img.medsci.cn/Random/filling-medical-history-XZB9RVX.jpg, journalId=0, articlesId=null, associationId=450, associationName=欧洲皮肤病学论坛, associationIntro=The practice of dermatology has, over the past 30 years, been distinguished by its transition from provision of essentially empirical treatments to a practice in which rational therapies, based on enhanced knowledge of the pathogenesis of disease, are administered. Coincidentally, the boundaries between organ specific specialities such as our own have become blurred. Thus there is now great overlap with numerous other medical disciplines. These include: oncology, immunology / allergology, plastic surgery, oral medicine and, increasingly rheumatology and other disciplines in which management of chronic inflammatory disease plays an important role., copyright=0, guiderPublishedTime=Thu Mar 07 00:00:00 CST 2024, originalUrl=, linkOutUrl=, content=<div class="guideDetailsCont flex-row-between-start" style="color: #333333;"> <div class="detailsContRight" style="color: #222222;">光化性角化病(AK)是一种常见的皮肤角化细胞发育不良,是皮肤鳞状细胞癌(cSCC)的潜在前兆。本文主要针对AK以及上皮紫外线诱发的异常增生和区域癌化的诊断、治疗和预防提供指导建议。</div> </div>, tagList=[TagDto(tagId=57472, tagName=日光性角化病)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=39, categoryName=皮肤性病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100)], articleKeywordId=57472, articleKeyword=日光性角化病, articleKeywordNum=6, guiderKeywordId=57472, guiderKeyword=日光性角化病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1210, appHits=11, showAppHits=0, pcHits=41, showPcHits=1199, likes=0, shares=0, comments=0, approvalStatus=1, publishedTime=Fri Mar 08 14:10:00 CST 2024, publishedTimeString=2024-03-07, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Mar 08 10:35:55 CST 2024, updatedBy=8538692, updatedName=梅斯话题小助手, updatedTime=Fri Mar 08 11:27:30 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=上海, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2024 欧洲共识指南:日光性角化病、上皮紫外线诱发的异常增生和区域癌化的诊断、治疗和预防.pdf)])
2024 欧洲共识指南:日光性角化病、上皮紫外线诱发的异常增生和区域癌化的诊断、治疗和预防.pdf
下载请点击:
评论区 (0)
#插入话题

拓展阅读

WHO图文精简笔记 || ​日光性角化病

日光性角化病是阳光损害的皮肤发生的一种常见表皮内瘤,以上皮细胞不同程度的非典型增生为特征。

这些面部色素性增生物一定要警惕!

今天我们来看看常见的癌前期增生物以及恶性增生物。

JAMA:卡培他滨用于治疗和预防日光性角化、鳞状细胞癌和基底细胞癌的评估

某些患者群体,如实体器官移植受者(SOTR),患皮肤癌的风险显著增加,但卡培他滨可能与SOTR中SCC发生率的降低以及AK和BCC的可能减少有关。

Br J Dermatol:治疗日光性角化病,光动力疗法是咪喹莫特更有效

背景:日光性角化病(solar keratosis,AK)又称老年角化病,多见于中年以上男性。主要发生于暴光部位,皮损为褐色角化性斑片,表面覆以不易剥离的黑褐色鳞屑。常单发。病程慢性。若皮损迅速扩大呈疣状或结节状,甚至破溃,则提示有恶化鳞癌的可能。在实体器官移植受者(OTR)中的日光性角化病在恶化为肿瘤之前的治疗是很困难的,因此临床医生需要比较局部治疗的疗效。目标:研究旨在探讨在个体研究中,与咪喹